Inca Kusters

An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults

Karin Levie, Isabel Leroux‐Roels, Karel Hoppenbrouwers et al. · The Journal of Infectious Diseases · 2008 · 118 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes

Jérôme Honnorat, Tamara Byk, Inca Kusters et al. · European Journal of Neuroscience · 1999 · 72 citations

Life Sciences, Neurology, Neuroscience +12

AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice

Catherine Caillet, Fabienne Piras, Marie‐Clotilde Bernard et al. · Vaccine · 2010 · 53 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

The C-Terminal Region but Not the Arg-X-Pro Repeat of Epstein-Barr Virus Protein EB2 Is Required for Its Effect on RNA Splicing and Transport

Monique Buisson, Fabienne Hans, Inca Kusters et al. · Journal of Virology · 1999 · 50 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age

Timo Vesikari, Stéphanie Pépin, Inca Kusters et al. · Human Vaccines & Immunotherapeutics · 2012 · 34 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17